SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is gaining significant community attention as traders discuss a potential breakout from its consolidation channel, with many pointing to upward momentum and comparisons to other fintech platforms as key drivers. Active discussion centers on price action near resistance levels, analyst upgrades, and the ongoing tug-of-war between optimistic bulls expecting a squeeze and skeptics wary of previous failed rallies.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is trending as investors debate whether the stock's recent price consolidation represents a deep value opportunity ahead of earnings or a long-term decline in market share. The community is actively tracking potential institutional accumulation and short interest while speculating on the impact of Pepsi's distribution and the performance of newer product lines.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending as positive regulatory momentum surrounding the CLARITY Act and the rising price of Bitcoin drive a technical breakout on heavy volume. The community is actively debating whether this move signals a sustainable reversal or a bull trap, with many traders closely tracking the stock's performance against key resistance levels.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense investor focus and massive trading volume following a new international defense contract, sparking heavy debate over a potential short squeeze and the company's long-term growth prospects. The community remains sharply divided between bulls citing the strong defense backlog and technical support levels, and bears pointing to ongoing dilution and negative sentiment as reasons for the stock's recent volatility.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as high volume and unusual institutional activity fuel a technical breakout, with community members actively discussing a potential short squeeze and high-growth potential ahead of key clinical data readouts. Investors are particularly focused on the upcoming NSCLC pipeline updates, citing deep institutional accumulation and ongoing speculation about a potential strategic partnership or acquisition as key drivers for the current upward momentum.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicor is experiencing high volatility as investors weigh the company's strong Q2 revenue beat and positive long-term AI power infrastructure thesis against concerns regarding the sustainability of its recent rapid price run-up. The community remains deeply divided, with some traders aggressively shorting the stock citing rich valuations, while bulls continue to accumulate, betting on the long-term potential of the firm's proprietary power delivery technology within the AI data center supply chain.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is currently trading in the spotlight as investors track the commercial rollout of ZEVASKYN, particularly following the activation of its seventh Qualified Treatment Center, Cincinnati Children's. The community is actively debating the company's long-term potential, focusing on commercial execution, low debt levels, and the anticipated 'snowball effect' of patient onboarding, while others express frustration over share price volatility and the pace of treatment uptake.

T3 Defense, Inc. is a federated holding company focused on acquiring and operating mission-critical defense businesses embedded in long-cycle national security programs. The firm targets defense businesses operating at constrained, qualification-driven, or execution-critical points across the industrial base, where strategic value exists and where qualification, capacity, and execution are decisive. T3 Defense strengthens critical defense capabilities and compounds long-term value through disciplined M&A, centralized strategy and capital, and decentralized operations. The company was founded on May 24, 2019 and is headquartered in New York, NY.

T3 Defense Inc. - Ordinary Shares - New

T3 Defense is seeing extreme volatility as investors weigh the company's recent acquisition of a drone and counter-UAV technology firm against ongoing concerns regarding dilution and a pending reverse stock split. The community remains deeply divided, with some traders targeting a potential squeeze driven by the company's low market cap and defense-sector contracts, while others dismiss the stock as a dilution-heavy trap.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending as investors react to the company's recent Phase 3 trial enrollment milestone and broader optimism surrounding potential federal policy shifts in the psychedelic biotech sector. The community is actively debating the stock's future, balancing enthusiasm for the company's clinical progress against concerns regarding management turnover and historical dilution.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple (XRP) is trending as investors closely monitor the Crypto Clarity Act and upcoming legislative developments, sparking intense community debate over potential impacts on adoption versus ongoing price stagnation. The discourse is heavily divided between bulls anticipating a breakout on regulatory clarity and bears expressing frustration over the asset's persistent lack of momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PPG Industries Boosts Shareholder Returns With 4.2% Dividend Hike 

PPG raises its quarterly dividend to 74 cents per share, extending a dividend streak dating to 1899 and highlighting confidence in long-term cash flow growth. 

AREC's ReElement Gets $25M to Expand Domestic Rare Earth Refining Hub 

American Resources secures $25M from the U.S. Department of War to expand rare earth refining in Indiana, boosting domestic critical mineral supply for defense. 

BASFY's Preliminary Q2 Sales Rise, FY26 Earnings Outlook Raised 

BASF lifts its 2026 EBITDA outlook after preliminary Q2 sales rose 16% to EUR 17.2B and net income climbed to EUR 4.1B. 

Here's Why You Should Retain Nutrien Stock in Your Portfolio 

NTR is riding healthy fertilizer demand, record potash sales and cost cuts, but higher input costs challenge margin gains.

ArcelorMittal Shares Pop 105% in a Year: What's Behind the Surge? 

MT stock has rallied 104.6% in the past year as higher steel output, record Liberia iron ore shipments and expansion projects support growth and capacity. 

Here's Why You Should Retain Reliance Stock in Your Portfolio 

RS is riding strong end-market demand and acquisitions to fuel growth, even as weak chip and aerospace markets and aluminum costs pressure margins. 

CF Industries Boosts Shareholder Returns With 20% Dividend Hike 

CF raises its quarterly dividend by 20% as strong nitrogen demand, pricing and cash generation reinforce confidence in its long-term financial outlook. 

American Resources Chosen by U.S. DOE for Rare Earth Recovery Pilot 

AREC enters DOE award negotiations for a pilot project to recover rare earths from coal byproducts, advancing an integrated U.S. critical minerals supply chain. 

RS Shares Rise 23% in 6 Months: Here's What's Driving the Upside 

Reliance shares surged 23% in six months as record tons sold, strong demand and acquisitions that expanded growth markets helped it outperform industry trends. 

FEAM Adds Third Offtake Pact to Advance Fort Cady Commercialization 

5E Advanced Materials lands a 3rd offtake milestone in two months, adding a US insulation customer as Fort Cady builds its commercial pipeline toward financing. 

Idaho Strategic Resources, Inc. engages in the exploration and development of gold, silver and base metal deposits. It has a portfolio of mineral properties namely: Golden Chest Mine, Murray Gold Belt, Butte Highlands and Central Idaho. The company was founded by Grant Brackebusch on July 18, 1996 and is headquartered in Coeur d'Alene, ID.

Idaho Strategic Resources Inc

Bullish Sentiment

Too early to tell

Semiconductor stocks have been under significant selling pressure in recent weeks, leaving retail investors debating whether the worst is over or if more downside lies ahead. Cast your vote and let us know your reasoning in the comments.

Is the pullback in semiconductor stocks over? 
 
Explain your reasoning in the comments.

Current Price	$28.84
Prev Close	$27.64
Open	$28.02
Dividend Yield	0.00%
50-Day Moving Average	$35.85
Beta	1.00
Avg. Volume	276,856.16
PE Ratio	19.86

52-Week High	$54.70
52-Week Low	$16.03
Market Capitalization	$436.98M
EPS (Annual)	$1.14
Price to Book	3.74
Revenue Per Employee	$683,971.82

Feed

News

Sentiment

Earnings

Fundamentals

Info

IDRIdaho Strategic Resources Inc

Latest IDR News